Philadelphia Trust Company’s Novartis NVS Stock Holding History

Philadelphia Trust Company’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$412K	Hold	2,700	–	–	0.03%	177
2025 Q4	$372K	Hold	2,700	–	–	0.03%	188
2025 Q3	$346K	Hold	2,700	–	–	0.02%	189
2025 Q2	$327K	Hold	2,700	–	–	0.03%	191
2025 Q1	$301K	Sell	2,700 -14	-0.5%	-$1.49K	0.03%	202
2024 Q4	$264K	Hold	2,714	–	–	0.02%	209
2024 Q3	$312K	Hold	2,714	–	–	0.02%	198
2024 Q2	$289K	Hold	2,714	–	–	0.02%	184
2024 Q1	$263K	Hold	2,714	–	–	0.02%	199
2023 Q4	$274K	Hold	2,714	–	–	0.03%	187
2023 Q3	$276K	Hold	2,714	–	–	0.03%	186
2023 Q2	$274K	Sell	2,714 -298	-10%	-$29.8K	0.03%	196
2023 Q1	$277K	Hold	3,012	–	–	0.03%	190
2022 Q4	$273K	Hold	3,012	–	–	0.03%	190
2022 Q3	$229K	Hold	3,012	–	–	0.03%	193
2022 Q2	$255K	Hold	3,012	–	–	0.03%	186
2022 Q1	$264K	Sell	3,012 -200	-6%	-$17.3K	0.02%	200
2021 Q4	$281K	Hold	3,212	–	–	0.02%	207
2021 Q3	$263K	Hold	3,212	–	–	0.02%	208
2021 Q2	$293K	Hold	3,212	–	–	0.02%	205
2021 Q1	$275K	Hold	3,212	–	–	0.02%	198
2020 Q4	$303K	Hold	3,212	–	–	0.02%	182
2020 Q3	$279K	Hold	3,212	–	–	0.03%	178
2020 Q2	$281K	Hold	3,212	–	–	0.03%	157
2020 Q1	$265K	Hold	3,212	–	–	0.03%	147
2019 Q4	$304K	Hold	3,212	–	–	0.03%	176
2019 Q3	$279K	Hold	3,212	–	–	0.03%	183
2019 Q2	$293K	Sell	3,212 -373	-10%	-$31.6K	0.03%	186
2019 Q1	$309K	Hold	3,585	–	–	0.03%	177
2018 Q4	$276K	Sell	3,585 -304	-8%	-$23.7K	0.03%	160
2018 Q3	$300K	Buy	+3,889	New	+$287K	0.02%	177

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Philadelphia Trust Company's NVS Position: Q1 2026 in Review

Philadelphia Trust Company held its Novartis (NVS) position steady in Q1 2026 at 2,700 shares worth $412K. The position accounts for 0.03% of the portfolio, ranked #177.

Philadelphia Trust Company first reported a position in NVS in Q3 2018 and has held it in 31 quarters since. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Philadelphia Trust Company held 2,700 shares of Novartis worth $412K as of Q1 2026.
Philadelphia Trust Company left its Novartis share count unchanged in Q1 2026.
Novartis made up 0.03% of Philadelphia Trust Company's portfolio in Q1 2026, its #177 holding.
Philadelphia Trust Company first reported a position in Novartis in Q3 2018 and has held it in 31 quarters since.
1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Philadelphia Trust Company's 13F filing for Q1 2026, filed 13 May 2026.